loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 22063 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Takeda Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE (4)

    filter

    01 TAKEDA PHARMS USA (4)

    filter

    01 CAPSULE, EXTENDED RELEASE;ORAL (4)

    filter

    01 12.5MG;12.5MG;12.5MG;12.5MG (1)

    02 3.125MG;3.125MG;3.125MG;3.125MG (1)

    03 6.25MG;6.25MG;6.25MG;6.25MG (1)

    04 9.375MG;9.375MG;9.375MG;9.375MG (1)

    filter

    01 USA (4)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, EXTENDED RELE...
    9.375MG;9.375MG;9.375M...
    MYDAYIS
    USA
    22063
    2017-06-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, EXTENDED RELE...
    3.125MG;3.125MG;3.125M...
    MYDAYIS
    USA
    22063
    2017-06-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, EXTENDED RELE...
    12.5MG;12.5MG;12.5MG;1...
    MYDAYIS
    USA
    22063
    2017-06-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, EXTENDED RELE...
    6.25MG;6.25MG;6.25MG;6...
    MYDAYIS
    USA
    22063
    2017-06-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 22063

    Looking for CTD TGA MCC DOSSIER APPLICATION 22063 4

    19

    Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 22063 and regulatory information .

    proudly manufactured in the

    approval since 2017-06-20

    Takeda Pharmaceutical's MYDAYIS CAPSULE, EXTENDED RELEASE;ORAL, medication with 9.375MG;9.375MG;9.375MG;9.375MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

    18

    Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 22063 and regulatory information .

    proudly manufactured in the

    approval since 2017-06-20

    Takeda Pharmaceutical's MYDAYIS CAPSULE, EXTENDED RELEASE;ORAL, medication with 3.125MG;3.125MG;3.125MG;3.125MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

    17

    Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 22063 and regulatory information .

    proudly manufactured in the

    approval since 2017-06-20

    Takeda Pharmaceutical's MYDAYIS CAPSULE, EXTENDED RELEASE;ORAL, medication with 12.5MG;12.5MG;12.5MG;12.5MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

    16

    Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 22063 and regulatory information .

    proudly manufactured in the

    approval since 2017-06-20

    Takeda Pharmaceutical's MYDAYIS CAPSULE, EXTENDED RELEASE;ORAL, medication with 6.25MG;6.25MG;6.25MG;6.25MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

    Post Enquiry
    POST ENQUIRY